More News

24 Dec 2022 LegoChem Biosciences and Amgen Enter into a Multi-Target Research Collaboration and License Agreement for the Development of Antibody-Drug Conjugates
22 Dec 2022 Merck and Kelun-Biotech Announce Exclusive License and Collaboration Agreement for Seven Investigational Antibody-drug Conjugate Candidates for the Treatment of Cancer
22 Dec 2022 Lilly and ProQR to Expand RNA Editing Collaboration
20 Dec 2022 Kite to Acquire Tmunity Therapeutics to Pursue Next Generation CAR T-Cell Therapy Advancements in Cancer
19 Dec 2022 Sanofi and Innate Pharma Expand Collaboration for Natural Killer Cell Therapeutics in Oncology
15 Dec 2022 GSK and Wave Life Sciences announce collaboration to drive discovery and development of oligonucleotide therapeutics focusing on novel genetic targets
15 Dec 2022 Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
15 Dec 2022 Arthex announces regulatory milestones met in its program to develop ATX-01 in Myotonic Dystrophy Type 1
15 Dec 2022 Innovent and LG Chem Announce Strategic Collaboration for Tigulixostat, a Novel Non-Purine Xanthine Oxidase Inhibitor for the Treatment of Gout Disease
12 Dec 2022 Amgen Inc to Acquire Horizon Therapeutics plc
08 Dec 2022 Vertex and Entrada Therapeutics Establish Collaboration to Discover and Develop Endosomal Escape Vehicle (EEV) Therapeutics for Myotonic Dystrophy Type 1 (DM1)
07 Dec 2022 MorphoSys Out Licenses Pre-Clinical Oncology Program
06 Dec 2022 Caris Life Sciences and Hummingbird Bioscience Enter Into Collaboration to Advance Clinical Development of Anti-HER3 Therapy
06 Dec 2022 Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab
06 Dec 2022 Pfizer and Clear Creek Bio to Collaborate on a Research Program Targeting SARS-CoV-2 Papain-Like Protease
06 Dec 2022 AbbVie Launches Strategic Collaboration with HotSpot Therapeutics to Further Expand Immunology Pipeline
01 Dec 2022 Roivant and Pfizer Form New Vant Company Focused on Developing TL1A Drug Candidate for Inflammatory and Fibrotic Diseases
01 Dec 2022 BioNTech and Ryvu Therapeutics Enter into Global Collaboration to Develop and Commercialize Immuno-Modulatory Small Molecule Candidates
30 Nov 2022 Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-Focused Radiopharmaceutical Pipeline
29 Nov 2022 Envisagenics Announces Research Collaboration with Bristol Myers Squibb
29 Nov 2022 BigHat Biosciences Announces Research Collaboration with Merck
29 Nov 2022 Ribon Therapeutics Announces Acquisition of Pre-Clinical CD38 Program by Boehringer Ingelheim
29 Nov 2022 C4X Discovery Holdings plc: C4XD signs exclusive global licence worth up to $402 millionĀ¹ with AstraZeneca for the development and commercialisation of NRF2 Activator programme
29 Nov 2022 AstraZeneca to acquire Neogene Therapeutics, accelerating ambition in Oncology cell therapy
21 Nov 2022 Merck to Acquire Imago BioSciences, Inc.

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up